A New Line Of Sight
Into Targeted Cancer Therapies

Expanded Access Policy

Viewpoint’s investigational drugs are currently at a stage in development where we are focused on enrolling in our clinical studies and continuing to learn more about our investigational drugs’ safety and efficacy. At this time, we are not yet supporting expanded access requests for newly treated patients. As we continue to develop our clinical pipeline, we encourage you to check back on our website for updates regarding investigational drugs which may later be available through expanded access.